The Valley Desk

Clinical trial reportInfectious diseases and therapyPublished

A Phase 2 Trial Evaluating the Immunogenicity and Safety of an mRNA-Based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names GSK. Affiliation source

Institution
GSK

Publication record

Type
Clinical trial report
Venue
Infectious diseases and therapy
Published
Subject terms
Neuraminidase; Virus neutralization; Adverse Events; Hemagglutination Inhibition Assay; Neuraminidase Inhibition Assay; Mrna Vaccine; Next-generation Influenza Vaccine; Hemagglutinin, Influenza
PubMed ID
42875682
PubMed Central ID
PMC13751912
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal